Primary Antibodies

PrEST Antigen IQGAP2 IQ motif containing GTPase activating p

PrEST Antigen IQGAP2 IQ motif containing GTPase activating p

Recombinant protein fragment of Human IQGAP3 with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

Recombinant protein fragment of Human IQSEC1 with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

Recombinant protein fragment of Human IQSEC1 with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

PrEST Antigen IQSEC1 IQ motif and Sec7 domain 1, 100ul UN 16

PrEST Antigen IQSEC1 IQ motif and Sec7 domain 1, 100ul UN 16

Recombinant protein fragment of Human IRAK1 with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

Recombinant protein fragment of Human IRAK2 with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

Recombinant protein fragment of Human IRAK3 with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

Recombinant protein fragment of Human IRS1 with&nbspN-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag Application Blocking agent and positive assay control using corresponding antibodies. Physical

Recombinant protein fragment of Human ISCA1 with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.